Nevada and five other states are filing new lawsuits accusing a pharmaceutical company of using deceptive marketing to boost drug sales that fueled opioid overdose deaths. Nevada state Attorney General Adam Laxalt alleges in a civil complaint that Purdue Pharma minimized risks and overstated benefits of long-term use of narcotic opioids including OxyContin. Similar lawsuits have or are expected to be filed by Florida, North Carolina, North Dakota, Tennessee and Texas. Connecticut-based Purdue denied the claims in an email statement that said it will defend itself.